Weidemann F - Search Results

1

Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy.

Beer M, Weidemann F, Breunig F, Knoll A, Koeppe S, Machann W, Hahn D, Wanner C, Strotmann J, Sandstede J. Beer M, et al. Among authors: weidemann f. Am J Cardiol. 2006 May 15;97(10):1515-8. doi: 10.1016/j.amjcard.2005.11.087. Epub 2006 Mar 29. Am J Cardiol. 2006. PMID: 16679096

2

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study.

Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM. Weidemann F, et al. Circulation. 2003 Sep 16;108(11):1299-301. doi: 10.1161/01.CIR.0000091253.71282.04. Epub 2003 Sep 2. Circulation. 2003. PMID: 12952834 Clinical Trial.

3

The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.

Weidemann F, Breunig F, Beer M, Sandstede J, Störk S, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM. Weidemann F, et al. Eur Heart J. 2005 Jun;26(12):1221-7. doi: 10.1093/eurheartj/ehi143. Epub 2005 Feb 23. Eur Heart J. 2005. PMID: 15728649

4

Progression of Fabry cardiomyopathy.

Strotmann J, Breunig F, Wanner C, Weidemann F. Strotmann J, et al. Among authors: weidemann f. Clin Ther. 2007;29 Suppl A:S13-4. doi: 10.1016/s0149-2918(07)80120-2. Clin Ther. 2007. PMID: 17580235 Review. No abstract available.

5

[Cardiac involvement in Fabry's disease].

Weidemann F, Breunig F. Weidemann F, et al. Med Klin (Munich). 2008 Mar 15;103(3):161-5. doi: 10.1007/s00063-008-1023-1. Med Klin (Munich). 2008. PMID: 18344066 Review. German.

6

Early detection of Fabry disease: cardiac cases.

Weidemann F, Strotmann J. Weidemann F, et al. Clin Ther. 2008;30 Suppl B:S46. doi: 10.1016/s0149-2918(08)80039-2. Clin Ther. 2008. PMID: 18395138 No abstract available.

7

Heart valve involvement in Fabry cardiomyopathy.

Weidemann F, Strotmann JM, Niemann M, Herrmann S, Wilke M, Beer M, Voelker W, Ertl G, Emmert A, Wanner C, Breunig F. Weidemann F, et al. Ultrasound Med Biol. 2009 May;35(5):730-5. doi: 10.1016/j.ultrasmedbio.2008.10.010. Epub 2008 Dec 24. Ultrasound Med Biol. 2009. PMID: 19110366

8

[Division-related function and organ-related therapy in Fabry's disease. An interdisciplinary challenge].

Weidemann F, Sommer C, Duning T, Lanzl I, Möhrenschlager M, Naleschinski D, Baron R, Breunig F, Schaefer R, Strotmann J, Wanner C. Weidemann F, et al. Med Klin (Munich). 2009 Jan 15;104(1):10-9. doi: 10.1007/s00063-009-1003-0. Epub 2009 Jan 14. Med Klin (Munich). 2009. PMID: 19142592 Review. German.

9

Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.

Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, Störk S, Voelker W, Ertl G, Wanner C, Strotmann J. Weidemann F, et al. Circulation. 2009 Feb 3;119(4):524-9. doi: 10.1161/CIRCULATIONAHA.108.794529. Epub 2009 Jan 19. Circulation. 2009. PMID: 19153271

10

The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapy.

Niemann M, Breunig F, Beer M, Herrmann S, Strotmann J, Hu K, Emmert A, Voelker W, Ertl G, Wanner C, Weidemann F. Niemann M, et al. Among authors: weidemann f. Heart. 2010 Dec;96(23):1915-9. doi: 10.1136/hrt.2010.204586. Epub 2010 Oct 21. Heart. 2010. PMID: 20965976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters